OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy
Roger Sun, Marvin Lerousseau, Jade Briend-Diop, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 10, pp. e004867-e004867
Open Access | Times Cited: 23

Showing 23 citing articles:

Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer
Zepang Sun, Taojun Zhang, M. Usman Ahmad, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10

Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
Ankit Mangla, Chanmi Lee, Matthew M. Mirsky, et al.
JAMA Oncology (2024) Vol. 10, Iss. 5, pp. 612-612
Open Access | Times Cited: 9

Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures
Song‐Bin Guo, Danqi Pan, Ning Su, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma
Alexandra Tompkins, Zane Gray, Rebekah Dadey, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e009568-e009568
Open Access

Radiomic-based approaches in the multi-metastatic setting: a quantitative review
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access

Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy
Jeremy McGale, Jakob Hama, Randy Yeh, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3065-3065
Open Access | Times Cited: 8

Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
Ernesto Rossi, Luca Boldrini, Maria Grazia Maratta, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7

Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma
Ryan C. Augustin, Jason J. Luke
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 421-434
Closed Access | Times Cited: 1

Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
Computerized Medical Imaging and Graphics (2024) Vol. 116, pp. 102413-102413
Open Access | Times Cited: 1

Textural heterogeneity of liver lesions in CT imaging - comparison of colorectal and pancreatic metastases
Friedrich L. Pietsch, Florian Haag, Isabelle Ayx, et al.
Abdominal Radiology (2024) Vol. 49, Iss. 12, pp. 4295-4306
Open Access | Times Cited: 1

Radiomic-Based Approaches in the Multi-metastatic Setting: a Quantitative Review
Caryn Geady, Hemangini Patel, Jacob Peoples, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective
Stefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 101-101
Open Access | Times Cited: 1

Radiotherapy and immunotherapy combinations for cancer treatment: past, present and future
Silvia C. Formenti, Sana D. Karam, Fernanda G. Herrera, et al.
(2024)
Closed Access

TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
Stefania Crucitta, Federico Cucchiara, Riccardo Marconcini, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access

In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
Mishal Mendiratta‐Lala, Issam El Naqa, Dawn Owen
Translational Cancer Research (2023) Vol. 12, Iss. 4, pp. 709-712
Open Access

Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease
Caryn Geady, Farnoosh Abbas‐Aghababazadeh, Andrés Kohan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top